http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021308071-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5dcc8a269f91712623c0f629541c807e |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-67 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-9066 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-9068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-8962 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-61 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-8962 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-9068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-9066 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-67 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-30 |
| filingDate | 2021-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48c8c9f4d3bbab6b58a6ae2146d5e2c4 |
| publicationDate | 2021-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2021308071-A1 |
| titleOfInvention | Treatment method to abort and or reduce the severity of upper respiratory viral illness as well as to prevent upper respiratory viral illness in humans |
| abstract | Upper respiratory viral illness including influenza is a common worldwide problem. The consequences of these infections in any given population have a huge spectrum including losing several workdays all the way to severe illness with prolonged hospitalizations and death. While there are a wide variety of symptomatic treatments available, they are neither shown to alter the disease course nor prevent the occurrence of secondary complications. There are no options available to get rid of these infections before the infection becomes a full blown illness. After various preventive methods like vaccines, hand hygiene, wearing masks and avoiding exposure, the next best step is to make use of treatment methods that do not necessitate a doctor visit or expensive diagnostic tests, to get rid of the illness quickly. The inventor here describes an invention of a treatment method to abort and/or reducing the severity either in its duration or symptoms or both of upper respiratory viral illness using a unique gargling solution comprising of Menthol, Borneol and Sodium Chloride dissolved in warm water, wherein the three compounds work in synergy for the above mentioned purpose. n As I continued researching other additional ways to further improve outcomes in humans with upper respiratory viral illness, I also formulated an additional treatment method to create a multi target therapy. This additional oral treatment to be used in conjunction with the above gargling method to ensure the best outcome for everyone with the said illness but particularly for individuals whose immune system may be already stressed. This oral formulation is a carefully formulated mixture of Curcumina Longa root powder along with Curcumin extract, Piper Nigrum, Ascorbic acid, Zinc, Echinacea, Sambucus Nigra, Allium Sativum, Syzygium Aromaticum, Coleus Amboinicus and Zingiber Officinale to be taken orally. |
| priorityDate | 2020-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 87.